Cargando…
Small molecules targeting histone demethylase genes (KDMs) inhibit growth of temozolomide-resistant glioblastoma cells
In glioblastoma several histone demethylase genes (KDM) are overexpressed compared to normal brain tissue and the development of Temozolomide (TMZ) resistance is accompanied by the transient further increased expression of KDM5A and other KDMs following a mechanism that we defined as “epigenetic res...
Autores principales: | Banelli, Barbara, Daga, Antonio, Forlani, Alessandra, Allemanni, Giorgio, Marubbi, Daniela, Pistillo, Maria Pia, Profumo, Aldo, Romani, Massimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471020/ https://www.ncbi.nlm.nih.gov/pubmed/28432280 http://dx.doi.org/10.18632/oncotarget.16820 |
Ejemplares similares
-
Targeting of Histone Demethylases KDM5A and KDM6B Inhibits the Proliferation of Temozolomide-Resistant Glioblastoma Cells
por: Romani, Massimo, et al.
Publicado: (2019) -
MicroRNA in Glioblastoma: An Overview
por: Banelli, Barbara, et al.
Publicado: (2017) -
Clinical Potentials of Methylator Phenotype in Stage 4 High-Risk Neuroblastoma: An Open Challenge
por: Banelli, Barbara, et al.
Publicado: (2013) -
Epigenetic Targeting of Glioblastoma
por: Romani, Massimo, et al.
Publicado: (2018) -
Inflammation, HIF-1, and the Epigenetics That Follows
por: Brigati, Claudio, et al.
Publicado: (2010)